Literature DB >> 14977687

Current concepts in anabolic-androgenic steroids.

Nick A Evans1.   

Abstract

Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone. According to surveys and media reports, the legal and illegal use of these drugs is gaining popularity. Testosterone restores sex drive and boosts muscle mass, making it central to 2 of society's rising preoccupations: perfecting the male body and sustaining the male libido. The anabolic effects of AAS have been questioned for decades, but recent scientific investigation of supraphysiologic doses supports the efficacy of these regimens. Testosterone has potent anabolic effects on the musculoskeletal system, including an increase in lean body mass, a dose-related hypertrophy of muscle fibers, and an increase in muscle strength. For athletes requiring speed and strength and men desiring a cosmetic muscle makeover, illegal steroids are a powerful lure, despite the risk of subjective side effects. Recent clinical studies have discovered novel therapeutic uses for physiologic doses of AAS, without any significant adverse effects in the short term. In the wake of important scientific advances during the past decade, the positive and negative effects of AAS warrant reevaluation. Guidelines for the clinical evaluation of AAS users will be presented for sports medicine practitioners.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977687     DOI: 10.1177/0363546503262202

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  56 in total

Review 1.  Performance-enhancing substances in sports: a review of the literature.

Authors:  Amit Momaya; Marc Fawal; Reed Estes
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

Review 2.  Testosterone and doping control.

Authors:  C Saudan; N Baume; N Robinson; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

Review 3.  Biological augmentation of rotator cuff tendon repair.

Authors:  David Kovacevic; Scott A Rodeo
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

4.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

5.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

6.  Psychosocial correlates of gap time to anabolic-androgenic steroid use.

Authors:  Patrycja Klimek; Tom Hildebrandt
Journal:  Int J Eat Disord       Date:  2018-03-15       Impact factor: 4.861

7.  Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres.

Authors:  M M Hamdi; G Mutungi
Journal:  J Physiol       Date:  2009-12-14       Impact factor: 5.182

8.  Matrix metallopeptidase 2 activity in tendon regions: effects of mechanical loading exercise associated to anabolic-androgenic steroids.

Authors:  Rita C Marqueti; Jonato Prestes; Milena Paschoal; Oscar H P Ramos; Sérgio E A Perez; Hernandes F Carvalho; Heloisa S Selistre-de-Araujo
Journal:  Eur J Appl Physiol       Date:  2008-09-23       Impact factor: 3.078

Review 9.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

10.  Effects of different doses of nandrolone decanoate on estrous cycle and ovarian tissue of rats after treatment and recovery periods.

Authors:  Vinícius Augusto Simão; Larissa Berloffa Belardin; Gabriel Adan Araújo Leite; Luiz Gustavo de Almeida Chuffa; Isabel Cristina Cherici Camargo
Journal:  Int J Exp Pathol       Date:  2015-11-17       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.